RxDoctor Payments Data

Adarsh Thaker, MD

Gastroenterology · Los Angeles, CANPI 1316200777

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $153,235 of the $241,048 with a category attached, or 63.6%. Boston Scientific accounts for 80.4% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $65,425, more than ten times the $3,381 reported in 2019. Among gastroenterology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$241,048in general payments, 2019–2025

Across 547 payments — averaging $440.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$194K
  • Apollo Endosurgery US Inc$25K
  • US Endoscopy$5K
  • Steris Corporation$3K
  • Olympus Medical Systems Corporation$3K
  • Cook Incorporated$3K
  • plus $8K from 20 others

What the payments were for

  • Consulting fees$46,86319%
  • Speaking & faculty fees$153,23564%
  • Travel & lodging$18,1438%
  • Food & beverage$22,8079%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$241,048 in reported general payments places this provider in the 95th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California →

Medicare billing

Part B allowed, 2024
$84,553
Medicare patients
274
Services billed
529

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates16$1,051
Pantoprazole Sodium25$349
Omeprazole28$298

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →